Growth Metrics

Voyager Therapeutics (VYGR) Net Income towards Common Stockholders (QoQ) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Voyager Therapeutics 230.25 Mn 88.77 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.86%
Dec 31, 2025 1.67%
Sep 30, 2025 16.45%
Jun 30, 2025 -7.61%
Mar 31, 2025 10.05%
Dec 31, 2024 -281.32%
Sep 30, 2024 10.82%
Jun 30, 2024 10.49%
Mar 31, 2024 -120.09%
Dec 31, 2023 317.73%
Sep 30, 2023 -16.63%
Jun 30, 2023 -117.90%
Mar 31, 2023 625.03%
Dec 31, 2022 -234.06%
Sep 30, 2022 192.34%
Jun 30, 2022 10.47%
Mar 31, 2022 -473.43%
Dec 31, 2021 122.71%
Sep 30, 2021 11.91%
Jun 30, 2021 -11.60%
Mar 31, 2021 -60.56%
Dec 31, 2020 -118.60%
Sep 30, 2020 1,091.44%
Jun 30, 2020 63.18%
Mar 31, 2020 -86.54%
Dec 31, 2019 16.21%
Sep 30, 2019 -234.55%
Jun 30, 2019 141.05%
Mar 31, 2019 -20.59%
Dec 31, 2018 -11.05%
Sep 30, 2018 20.56%
Jun 30, 2018 -28.18%
Mar 31, 2018 -68.89%
Dec 31, 2017 49.46%
Sep 30, 2017 -23.68%
Jun 30, 2017 -13.38%
Mar 31, 2017 -13.45%
Dec 31, 2016 -63.12%
Sep 30, 2016 3.63%
Jun 30, 2016 -29.87%
Mar 31, 2016 18.48%
Dec 31, 2015 -27.52%
Sep 30, 2015 -2.49%
Jun 30, 2015 57.34%
Mar 31, 2015 -204.27%
Dec 31, 2014 -17.82%